Symmetry Partners LLC Invests $278,000 in Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY)
Symmetry Partners LLC bought a new position in shares of Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 1,144 shares of the biopharmaceutical company’s stock, valued at approximately $278,000. Other institutional investors have also recently added to […]
More Stories
Justin Charles Guichard Buys 7,364 Shares of Brookfield Real Assets Income Fund Inc. (NYSE:RA) Stock
Brookfield Real Assets Income Fund Inc. (NYSE:RA – Get Free Report) Portfolio Manager Justin Charles Guichard purchased 7,364 shares of...
Deal W. Hudson Sells 2,500 Shares of Atlanticus Holdings Co. (NASDAQ:ATLC) Stock
Atlanticus Holdings Co. (NASDAQ:ATLC – Get Free Report) Director Deal W. Hudson sold 2,500 shares of Atlanticus stock in a...
Michael J. Labarre Sells 10,000 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO) Stock
Halozyme Therapeutics, Inc. (NASDAQ:HALO – Get Free Report) SVP Michael J. Labarre sold 10,000 shares of the company’s stock in...
Steve Ladd Huffman Sells 14,000 Shares of Reddit, Inc. (NYSE:RDDT) Stock
Reddit, Inc. (NYSE:RDDT – Get Free Report) CEO Steve Ladd Huffman sold 14,000 shares of the business’s stock in a...
Full House Resorts, Inc. (NASDAQ:FLL) CEO Sells $59,506.59 in Stock
Full House Resorts, Inc. (NASDAQ:FLL – Get Free Report) CEO Daniel R. Lee sold 11,737 shares of the company’s stock...
Royal Bank of Canada (TSE:RY) Senior Officer Sells C$24,817.82 in Stock
Royal Bank of Canada (TSE:RY – Get Free Report) (NYSE:RY) Senior Officer Erica Lesley Nielsen sold 148 shares of the...